A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data

Diabetes is a significant and independent risk factor for atherosclerotic cardiovascular disease (ASCVD), leading to morbidity and mortality among this population. The prevention of macrovascular complications, such as CVD, peripheral arterial disease, and cerebrovascular accident, in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rana, Khyatiben, Reid, Jessica, Rosenwasser, Joshua N, Lewis, Todd, Sheikh-Ali, Mae, Choksi, Rushab R, Goldfaden, Rebecca F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756838/
https://www.ncbi.nlm.nih.gov/pubmed/31571964
http://dx.doi.org/10.2147/DMSO.S167375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756838/
https://www.ncbi.nlm.nih.gov/pubmed/31571964
http://dx.doi.org/10.2147/DMSO.S167375

Ejemplares similares